CIBC Private Wealth Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.2M | Buy |
218,329
+12,818
| +6% | +$4.18M | 0.13% | 162 |
|
|
2025
Q1 | $46.1M | Buy |
205,511
+2,143
| +1% | +$481K | 0.1% | 176 |
|
|
2024
Q4 | $48.9M | Sell |
203,368
-5,118
| -2% | -$1.23M | 0.09% | 174 |
|
|
2024
Q3 | $57.3M | Buy |
208,486
+2,095
| +1% | +$576K | 0.1% | 171 |
|
|
2024
Q2 | $52.7M | Buy |
206,391
+32,142
| +18% | +$8.2M | 0.1% | 168 |
|
|
2024
Q1 | $26.7M | Buy |
174,249
+548
| +0.3% | +$84K | 0.05% | 236 |
|
|
2023
Q4 | $33.2M | Sell |
173,701
-429
| -0.2% | -$82.1K | 0.07% | 214 |
|
|
2023
Q3 | $30.8M | Sell |
174,130
-382
| -0.2% | -$67.7K | 0.07% | 211 |
|
|
2023
Q2 | $33.1M | Buy |
174,512
+53,531
| +44% | +$10.2M | 0.07% | 218 |
|
|
2023
Q1 | $24.2M | Sell |
120,981
-885
| -0.7% | -$177K | 0.05% | 225 |
|
|
2022
Q4 | $28.6M | Buy |
121,866
+2,458
| +2% | +$577K | 0.1% | 140 |
|
|
2022
Q3 | $23.9M | Buy |
119,408
+3,166
| +3% | +$634K | 0.06% | 198 |
|
|
2022
Q2 | $17M | Sell |
116,242
-4,035
| -3% | -$588K | 0.04% | 250 |
|
|
2022
Q1 | $19.6M | Buy |
120,277
+2,025
| +2% | +$331K | 0.04% | 252 |
|
|
2021
Q4 | $20.1M | Sell |
118,252
-893
| -0.7% | -$151K | 0.04% | 259 |
|
|
2021
Q3 | $22.5M | Buy |
119,145
+429
| +0.4% | +$81K | 0.05% | 232 |
|
|
2021
Q2 | $20.1M | Sell |
118,716
-7,544
| -6% | -$1.28M | 0.05% | 255 |
|
|
2021
Q1 | $17.8M | Buy |
+126,260
| New | +$17.8M | 0.04% | 262 |
|
|
2018
Q2 | – | Sell |
-5
| Closed | -$1K | – | 1949 |
|
|
2018
Q1 | $1K | Sell |
5
-7,550
| -100% | -$1.51M | ﹤0.01% | 1836 |
|
|
2017
Q4 | $960K | Buy |
+7,555
| New | +$960K | ﹤0.01% | 660 |
|